Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 1, 1998, Pages 427-435

  Kilgore, Kenneth S ^a   Tanhehco, Elaine J ^a   Park, James L ^a   Naylor, Keith B ^a   Anderson, Mark B ^a,b   Lucchesi, Benedict R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Glycomed Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,7 BIS(CARBOXYETHYL) 6 CARBOXYFLUORESCEIN; CARBOHYDRATE DERIVATIVE; DIANISIDINE; DRUG VEHICLE; GLUCURONIC ACID; GLYCOSIDE; GLYCYRRHETINIC ACID; GLYCYRRHIZIC ACID; GLYCYRRHIZIC ACID DERIVATIVE; GM 3290; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; PADGEM PROTEIN; SIALIC ACID DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; HEART INFARCTION SIZE; HEART PROTECTION; HEMODYNAMICS; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE ADHERENCE; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; UMBILICAL VEIN;

ANIMALS; CELL ADHESION; GLYCYRRHIZIC ACID; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; MYOCARDIAL INFARCTION; NEUTROPHILS; P-SELECTIN; PEROXIDASE; RABBITS;

EID: 0031887628     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ambrosio G and Chiariello M (1985) Myocardial reperfusion injury: Mechanisms and management: A review. Am. J. Med. 91:86S.
2. Bradley PP, Priebat DA, Christensen RD and Rothstein G (1982) Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78:206-209.
3. Buerke M, Weyrich AS, Zheng A, Gaeta FCA, Forrest MJ and Lefer AM (1994) Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J. Clin. Invest. 93:1140-1144.
4. Butcher EC (1992) Leukocyte-endothelial cell adhesion as an active, multi-step process: A combinational mechanism for specificity and diversity in leukocyte targeting, in Mechanisms of Lymphocyte Activation and Immune Regulation IV: Cellular Communications (Gupta S and Waldamann TA eds) pp 181-194, Plenum Press, New York.
5. Foreman KE, Vaporciyan AA, Bonish BK, Jones ML, Johnson KJ, Glovsky MM, Eddy SM and Ward PA (1994) C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147-1155.
6. Ichikawa Y, Mizoguchi Y, Kioka K, Kobayashi K, Tomekawa K, Morosawa S and Yamamoto S (1989) Effect of glycyrrhizin on the production of platelet-activating factor from rat peritoneal exudate cells. Arerugi 38:365-369.
7. Jaffe EA (1984) Culture and identification of large vessel endothelial cells, in Biology of Endothelial Cells (Jaffe EA ed) p 13, Martinus Nijoff, The Hague.
8. Jutila MA, Rott L, Berg EL and Butcher EC (1989) Function and regulation of the neutrophil MEL-14 antigen in vivo: Comparison with LFA-1 and MAC-1. J. Immunol. 143:3318-3324.
9. Kilgore KS and Lucchesi BR (1993) Effect of hypoxia and reoxygenation on the isolated rabbit heart determined by monoclonal antimyosin antibody uptaki Cardiovasc. Res. 27:1260-1267.
10. Kilgore KS, Park JL, Chi L, Musser JH and Luchessi BR (1996) Reduction of myocardial infarct size in the rabbit by a carbohydrate analog of sialyl Lewisx. J. Cardiovasc. Pharmacol. Ther. 1:49-56.
11. Kishimoto TM, Jutila MA, Berg EL and Butcher EC (1989) Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245:1238-1241.
12. Kroes BH, Beukelman CJ, Van Den Berg AJJ, Wolbink GJ, Van Dijk H and Labadie RP (1997) Inhibition of human complement by β-glycyrrhetinic acid. Immunology 90:115-120.
13. Langlois PF and Gawryl MS (1988) Detection of the terminal complement complex in patient plasma following acute myocardial infarction. Atherosclerosis 77:95-105
14. Ma X-L, Tsao PS and Lefer AM (1991) Antibody to CD-18 exerts endothelial and cardioprotective effects in myocardial ischemia and reperfusion. J. Clin. Invest. 88:1237-1243.
15. Ma X-L, Weyrich AS, Lefer DJ, Buerker M, Albertine KH, Kishimoto TK and Lefer AM (1993) Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium. Circulation 88:649-658.
16. Matsushima Y and Baba T (1992) An antigranulomatous effect of glycyrrhizin. J. Exp. Pathol. 6:25-30.
17. Mullane KM, Read N, Salmon JA and Moncada S (1984) Role of leukocytes in acute myocardial infarction in anesthetized dogs: Relationship to myocardial salvage by anti-inflammatory drugs. J. Pharmacol. Exp. Ther. 228:510-522.
18. Mulligan MS, Hevel JM, Marletta MA and Ward PA (1991) Tissue injury caused by deposition of immune complexes is L-arginine dependent. Proc. Natl. Acad. Sci. U.S.A. 88:6338-6343.
19. Musser J, Rao N, Nashed MA, Dasgupta F, Abbas S, Nematalla A, Dat, V, Foxall M, Asa D, James P, Tyrrell D and Brandley BK (1993) Structure-activity studies based on the sialyl Lewis X epitope. in Trends in Receptor Research (Claassen V ed) pp 33-40, Elsevier, New York.
20. Musser J, Fugedi J and Anderson MB (1995) Carbohydrate-based therapeutics. in Burger's Medicinal Chemistry (Wolff ME ed) vol 1, pp 901-947, Wiley, New York.
21. Musser J, Anderson MB and Fugedi P (1996) Glycomimetics: An approach to discovering leads for novel therapeutics. Pharm. News 3:11-17.
22. Nakamura T, Fujii T and Ichihara A (1985) Enzyme leakage due to change of membrane permeability of primary cultured rat hepatocytes treated with various hepatotoxins and its prevention by glycyrrhizin. Cell Biol. Toxicol. 1:285-295.
23. Nathan CF (1987) Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550-1560.
24. Nathan CF (1989) Respiratory burst in adherent human neutrophils: Triggering by colony-stimulating factors CSF-GM and CSF-G. Blood 73:301-306.
25. Numazaki K, Nagata N, Sato T and Chiba S (1994) Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor alpha on infection of U937 and MRC-5 cells by human cytomegalovirus. J. Leukocyte Biol. 55:24-28.
26. Parker CW (1991) Neutrophil mechanisms (abstract). Annu. Rev. Respir. Dis. 143:S59
27. Rao BNN, Anderson MB, Musser JH, Gilbert JH, Schaefer ME, Foxall C and Brandley BK (1994) Sialyl Lewisx mimics derived from a pharmacophore search are selectin inhibitors with anti-inflammatory activity. J. Biol. Chem. 269:19663-19666.
28. Romson JL, Hook BG, Kunkel SS, Abrams GD, Schork MA and Lucchesi BR (1983) Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation 67:1016-1023.
29. Simpson PJ, Todd RF III, Fantone JC, Mickelson JK, Griffin JD and Lucchesi BR (1988a) Reduction of experimental myocardial reperfusion injury by a monoclonal antibody (anti-Mol, anti-CD11b) that inhibits leukocyte adhesion. J. Clin. Invest. 81:624-629.
30. Simpson PJ, Fantone JC, Mickelson JK, Gallagher KP and Lucchesi BR (1988b) Identification of a time window for therapy to reduce experimental canine myocardial injury: Suppression of neutrophil activation during 72 hours of reperfusion. Circ. Res. 63:1070-1079.
31. Simpson PJ, Mickelson J, Fantone JC, Gallagher KP and Lucchesi BR (1988c) Reduction of experimental canine myocardial infarct size with prostaglandin E1: Inhibition of neutrophil migration and activation. J. Pharmacol. Exp. Ther. 244: 619-624.
32. Vaporciyan AA, Jones ML and Ward PA (1993) Rapid analysis of leukocyte-endothelial adhesion. J. Immunol. Methods 159:93-100.
33. Virmani R, Kolodgie FD, Forman MB, Farb A and Jones RM (1992) Reperfusion injury in the ischemic myocardium. Cardiovasc. Pathol. 1:117-129.
34. Von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE and Butcher EC (1991) Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte B2 integrins in vivo. Proc. Natl. Acad. Sci. U.S.A. 88:7538-7542.
35. 2O2 or products of activated neutrophils. Am. J. Med. 91:suppl. (3C), 89S-94S.
36. Werns SW, Shea MJ and Lucchesi BR (1985) Free radicals in ischemic myocardial injury. J. Free Radicals Biol. Med. 1:103-110.
37. Weyrich AS, Ma X-L, Lefer DJ, Albertine KH and Lefer AM (1993) In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J. Clin. Invest. 91:2620-2629.